- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 295/26 - Atomes de soufre
Détention brevets de la classe C07D 295/26
Brevets de cette classe: 367
Historique des publications depuis 10 ans
|
34
|
21
|
24
|
24
|
16
|
23
|
27
|
14
|
17
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 20556 |
16 |
| The Scripps Research Institute | 1341 |
16 |
| FUJIFILM Corporation | 30277 |
10 |
| Imago Biosciences, Inc. | 40 |
9 |
| F. Hoffmann-La Roche AG | 7839 |
8 |
| Canopy Growth Corporation | 211 |
8 |
| Cytokinetics, Inc. | 256 |
8 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2971 |
7 |
| H. Lundbeck A/S | 1238 |
7 |
| Janssen Pharmaceutica N.V. | 3234 |
6 |
| Board of Regents, The University of Texas System | 6045 |
6 |
| 3m Innovative Properties Company | 17509 |
5 |
| Omeros Corporation | 304 |
5 |
| University of Utah Research Foundation | 1857 |
5 |
| Allergan Sales, LLC | 245 |
4 |
| Axikin Pharmaceuticals, Inc. | 13 |
4 |
| Emory University | 1702 |
4 |
| Novira Therapeutics, Inc. | 32 |
4 |
| Tetraphase Pharmaceuticals, Inc. | 52 |
4 |
| Versitech Limited | 369 |
4 |
| Autres propriétaires | 227 |